Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Cryocompression for CIPN [NA]

View source ↗

Summary

A Dana-Farber Cancer Institute-led clinical trial is evaluating cryocompression for chemotherapy-induced peripheral neuropathy, including taxane-induced neuropa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Chemotherapy-induced Peripheral Neuropathy, Taxane-Induced Peripheral Neuropathy | NA | Status: RECRUITING